![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12P 21/08 | |
A61P 35/00 | |||
A61K 39/395 | |||
C07K 16/28 | |||
C07K 16/30 |
(11) | Number of the document | 2134854 |
(13) | Kind of document | T |
(96) | European patent application number | 08726810.8 |
Date of filing the European patent application | 2008-03-14 | |
(97) | Date of publication of the European application | 2009-12-23 |
(45) | Date of publication and mention of the grant of the patent | 2015-04-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2008/003369 |
Date | 2008-03-14 |
(87) | Number | WO 2008/115404 |
Date | 2008-09-25 |
(30) | Number | Date | Country code |
918084 P | 2007-03-15 | US |
(72) |
CAVENEE, Webster, US
FURNARI, Frank, US
JOHNS, Terrance, Grant, AU
SCOTT, Andrew, AU
|
(73) |
Ludwig Institute for Cancer Research Ltd.,
605 Third Avenue, New York, NY 10158,
US
|
(54) | TREATMENT METHOD USING EGFR ANTIBODIES AND SRC INHIBITORS AND RELATED FORMULATIONS |
TREATMENT METHOD USING EGFR ANTIBODIES AND SRC INHIBITORS AND RELATED FORMULATIONS |